Retatrutide is primarily being studied for individuals with obesity and metabolic disorders, where traditional lifestyle interventions or single-agonist therapies may fall short
In December 2025, the BBB National Programs' National Advertising Division said Willow had not established a reasonable basis for certain challenged advertising claims and recommended that the claims be modified or discontinued
Why This Question Matters Why This Question Matters Many people ask: Safe pa ba gamitin? Pwede pa ba kahit lampas expiry? Effective pa ba ito? Because when it comes to supplements, its not just about safety
10.1172/JCI34060 [DOI] [PMC free article] [PubMed] [Google Scholar] He L., He T., Farrar S., Ji L., Liu T., Ma X
Wegovy is approved for chronic weight management in people with obesity or overweight with weight-related health conditions
At MetFit-Rx, this doesn't mean casually taking less medication